OrbusNeich Medical Group Holdings Limited (HKG:6929)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.850
+0.030 (0.79%)
Apr 29, 2026, 3:59 PM HKT
-3.27%
Market Cap 3.14B
Revenue (ttm) 1.40B
Net Income (ttm) 326.12M
Shares Out 823.25M
EPS (ttm) 0.40
PE Ratio 9.66
Forward PE 9.13
Dividend 0.12 (3.16%)
Ex-Dividend Date Jun 10, 2026
Volume 40,500
Average Volume 44,110
Open 3.840
Previous Close 3.820
Day's Range 3.840 - 3.980
52-Week Range 3.450 - 5.710
Beta -0.74
RSI 49.32
Earnings Date Mar 12, 2026

About HKG:6929

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expan... [Read more]

Sector Healthcare
Founded 2001
Employees 1,477
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6929
Full Company Profile

Financial Performance

In 2025, HKG:6929's revenue was $180.45 million, an increase of 9.97% compared to the previous year's $164.10 million. Earnings were $41.90 million, an increase of 5.49%.

Financial numbers in USD Financial Statements

News

There is no news available yet.